ArticleCardiovascular diabetology2025
Interpretable machine learning analysis of immunoinflammatory biomarkers for predicting CHD among NAFLD patients.
Article in Cardiovascular diabetology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 29 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
29 citing papers in PubMed.
- Risk Factors for Cardiovascular Disease: Epidemiology, Screening, Prevention, and Therapeutic Interventions.MedComm · 2026Review
- The associations between systemic immune-inflammation index and IgE in children with allergic rhinitis: a case-control study.Pediatric research · 2026Article
- Development and external validation of machine learning models to predict insulin resistance among iron-deficient children and adolescents.Translational pediatrics · 2026Article
- An interpretable machine learning model for biomarker identification and diagnostic nomogram development in hypo-productive thrombocytopenia.Scientific reports · 2026Article
- Sex-Specific Association Between the Neutrophil-to-HDL Cholesterol Ratio and Hyperuricemia in Obstructive Sleep Apnea.Journal of clinical medicine · 2026Article
- Development and internal validation of an explainable machine-learning model to predict 3-year overall survival rate after radical cystectomy.BMC cancer · 2026Article
- Diabetes Mellitus Facilitates Gallstone Formation Through CXCR2-NETs-Mediated Liver-Bile Barrier Damage.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Combined lesion-specific pericoronary adipose tissue attenuation and triglyceride-glucose body mass index for improved risk stratification of major adverse cardiovascular events in patients with stable angina pectoris.Quantitative imaging in medicine and surgery · 2026Article
- A machine learning model based on routine blood-derived indices for early arterial stiffness prediction in the community.Lipids in health and disease · 2026Article
- Study of the prognostic value of the systemic immune-inflammation index combined with the triglyceride-glucose index in coronary heart disease: a retrospective study based on the MIMIC database.BMC cardiovascular disorders · 2026Article
- Integrin β3 Orchestrates Hepatic Steatosis via a Novel CD36-Dependent Lipid Uptake Complex.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Integrating lipid-related composite indices and explainable machine learning for coronary heart disease risk assessment.Frontiers in public health · 2026Article
- Association between the C-reactive protein-triglyceride-glucose index and coronary heart disease in metabolic dysfunction-associated steatotic liver disease patients: a cross-sectional study.Frontiers in endocrinology · 2026Article
- The associations of the triglyceride-glucose index and estimated glucose disposal rate with incident cardiometabolic multimorbidity vary across obesity phenotypes: a longitudinal cohort study.Frontiers in nutrition · 2026Article
- From proteome-wide Mendelian randomization and multi-omics integration to functional validation: TGFB3 as a prioritized candidate in gastric adenocarcinoma.Frontiers in oncology · 2026Article
- Baicalein attenuates extracellular matrix remodeling via FN1 in diabetic kidney disease: a multi-omics, machine-learning and mesangial-cell rescue study.Frontiers in pharmacology · 2026Article
- Multiscale characterization of an inflammatory macrophage state associated with an air pollutant-prioritized prognostic signature in gastric cancer.Frontiers in immunology · 2026Article
- Red blood cell distribution width to albumin ratio predicts mortality in heart failure patients with pneumonia.Frontiers in cardiovascular medicine · 2026Article
- An interpretable nomogram with SHAP analysis predicts thrombotic failure of forearm arteriovenous fistulas.Frontiers in surgery · 2026Article
- Construction of a Preoperative Prediction Model for TACE Resistance in Primary Hepatocellular Carcinoma Based on Machine Learning Algorithms.Journal of hepatocellular carcinoma · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCoronary Heart Disease (CHD) and Non-Alcoholic Fatty Liver Disease (NAFLD) share overlapping pathogenic mechanisms including adipose tissue dysfunction, insulin resistance, and systemic inflammation mediated by adipokines. However, the specific impact of inflammation and immune responses on CHD risk in NAFLD patients remains poorly understood. This study evaluated the predictive value of ten immunoinflammatory indexes for CHD risk in NAFLD patients using an interpretable machine learning framework.
methodsWe retrospectively analyzed 407 NAFLD patients undergoing coronary angiography, and stratifying them into NAFLD + CHD (n = 250) and NAFLD (n = 157) groups. Ten immunoinflammatory indexes were derived from the blood laboratory results. Lasso regression analysis and propensity score matching (PSM) were employed to mitigate confounding effects. Subsequently, univariate and multivariate logistic regression analyses were used to identify independent risk factors for CHD occurrence among NAFLD patients. While restricted cubic splines (RCS) and Receiver operating characteristic (ROC) curve evaluated the relationship between each immunoinflammatory indexes and CHD risk. Linear correlation methods were employed to evaluate the relationship between Gensini score and immunoinflammatory indexes. Finally, three machine learning algorithms (RF, SVM and GLM) were used to identify significant risk factors. To interpret the diagnostic model built by Random Forest, the SHapley Additive exPlanations (SHAP) method was employed, and features were ranked according to their SHAP values. Based on these rankings, a diagnostic nomogram was further constructed and the accuracy of the diagnostic model was evaluated using ROC curves.
resultAfter PSM, among the 282 included patients with NAFLD, 141 cases (50%) were complicated with CHD. Multivariate logistic regression analysis revealed that after adjusting for age, sex, hypertension, and smoking history, the NHR index was identified as the most significant risk factor for CHD in NAFLD patients (OR, 1.375; 95% CI, 1.021-1.852; P < 0.001). Additionally, NLR, SII, SIRI and NMR were also identified as risk factors. PNR was a protective factor for CHD events in patients with NAFLD. RCS analysis demonstrated linear relationships between the NHR, NLR, and PNR index with CHD occurrence, whereas the SII index exhibited a non-linear J-shaped relationship with CHD risk (non-linear P = 0.025). Correlation analysis with Gensini score showed that the NHR index had the highest correlation with the severity of CHD (R = 0.256, P < 0.001). ROC curves indicated that the NHR index had good predictive and diagnostic performance (AUC = 0.703,95% CI, 0.652-0.754). Finally, the diagnostic nomogram constructed based on SHAP values demonstrated good accuracy and predictive performance (AUC = 0.834,95% CI, 0.795-0.873; P < 0.001).
conclusionSix immunoinflammatory markers demonstrated significant associations with CHD risk in NAFLD populations, among which the NHR index exhibited particularly promising predictive potential.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.